BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CLTC, CLTCL2, 1213, ENSG00000141367, Q00610 AND Prognosis
13 results:

  • 1. Generation of the novel anti-FXYD5 monoclonal antibody and its application to the diagnosis of pancreatic and lung cancer.
    Hotta T; Nariai Y; Kajitani N; Kadota K; Maruyama R; Tajima Y; Isobe T; Kamino H; Urano T
    Biochimie; 2023 May; 208():160-169. PubMed ID: 36621663
    [TBL] [Abstract] [Full Text] [Related]  

  • 2.
    Shen H; Lundy J; Strickland AH; Harris M; Swan M; Desmond C; Jenkins BJ; Croagh D
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231137
    [No Abstract]    [Full Text] [Related]  

  • 3. Low-grade serous carcinoma detected from intraoperative peritoneal washings: Cytological findings and detection of KRAS mutation.
    Yamamoto E; Warigaya K; Kinoshita Y; Yamamoto A; Murata SI
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1676. PubMed ID: 35801373
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. KRAS gene mutation quantification in the resection or venous margins of pancreatic ductal adenocarcinoma is not predictive of disease recurrence.
    Amintas S; Fernandez B; Chauvet A; Chiche L; Laurent C; Belleannée G; Marty M; Buscail E; Dabernat S
    Sci Rep; 2022 Feb; 12(1):2976. PubMed ID: 35194118
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Okubo Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Hikichi T; Ohira H
    BMC Cancer; 2021 Dec; 21(1):1319. PubMed ID: 34886831
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chemotherapy-Induced Reduction of Neutrophil-to-Lymphocyte Ratio Is Associated With Better Survival in Pancreatic Adenocarcinoma: A Meta-Analysis.
    Luo X; Yu B; Jiang N; Du Q; Ye X; Li H; Wang WQ; Zhai Q
    Cancer Control; 2020; 27(1):1073274820977135. PubMed ID: 33269614
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic role of chemotherapy-induced nausea and vomiting in recurrent ovarian cancer patients: results of an individual participant data meta-analysis in 1213.
    Woopen H; Richter R; Chekerov R; Inci G; Alavi S; Grabowski JP; Sehouli J
    Support Care Cancer; 2020 Jan; 28(1):73-78. PubMed ID: 30980260
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Circulating tumor cells in pancreatic cancer : Results of morphological and molecular analyses and comparisons with the primary tumor].
    Timme-Bronsert S; Bronsert P; Werner M; Kulemann B; Höppner J
    Pathologe; 2018 Dec; 39(Suppl 2):311-314. PubMed ID: 30483865
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study.
    Nakano Y; Kitago M; Matsuda S; Nakamura Y; Fujita Y; Imai S; Shinoda M; Yagi H; Abe Y; Hibi T; Fujii-Nishimura Y; Takeuchi A; Endo Y; Itano O; Kitagawa Y
    Br J Cancer; 2018 Mar; 118(5):662-669. PubMed ID: 29360815
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
    Bolton KL; Chenevix-Trench G; Goh C; Sadetzki S; Ramus SJ; Karlan BY; Lambrechts D; Despierre E; Barrowdale D; McGuffog L; Healey S; Easton DF; Sinilnikova O; Benítez J; García MJ; Neuhausen S; Gail MH; Hartge P; Peock S; Frost D; Evans DG; Eeles R; Godwin AK; Daly MB; Kwong A; Ma ES; Lázaro C; Blanco I; Montagna M; D'Andrea E; Nicoletto MO; Johnatty SE; Kjær SK; Jensen A; Høgdall E; Goode EL; Fridley BL; Loud JT; Greene MH; Mai PL; Chetrit A; Lubin F; Hirsh-Yechezkel G; Glendon G; Andrulis IL; Toland AE; Senter L; Gore ME; Gourley C; Michie CO; Song H; Tyrer J; Whittemore AS; McGuire V; Sieh W; Kristoffersson U; Olsson H; Borg Å; Levine DA; Steele L; Beattie MS; Chan S; Nussbaum RL; Moysich KB; Gross J; Cass I; Walsh C; Li AJ; Leuchter R; Gordon O; Garcia-Closas M; Gayther SA; Chanock SJ; Antoniou AC; Pharoah PD; ; ;
    JAMA; 2012 Jan; 307(4):382-90. PubMed ID: 22274685
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Radiotherapy for bone metastases from hepatocellular carcinoma and pancreas cancer].
    Harada H; Nishimura T; Kamata M; Asakura H; Zenda S; Takahashi M; Katagiri H; Takagi T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1061-4. PubMed ID: 16912522
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epidemiology and therapy of thyroid cancer in childhood and adolescence.
    Bucsky P; Parlowsky T
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 4():70-3. PubMed ID: 9439921
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.